ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 45 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110 | +96.4% | 9,634 | +75.8% | 0.00% | – |
| Q2 2023 | $56 | +33.3% | 5,479 | -0.5% | 0.00% | – |
| Q1 2023 | $42 | +5.0% | 5,505 | +1.3% | 0.00% | – |
| Q4 2022 | $40 | -99.9% | 5,437 | 0.0% | 0.00% | – |
| Q3 2022 | $39,000 | -15.2% | 5,437 | +0.7% | 0.00% | – |
| Q2 2022 | $46,000 | -4.2% | 5,397 | 0.0% | 0.00% | – |
| Q1 2022 | $48,000 | -36.0% | 5,397 | 0.0% | 0.00% | – |
| Q4 2021 | $75,000 | +29.3% | 5,397 | -0.4% | 0.00% | – |
| Q3 2021 | $58,000 | -37.6% | 5,417 | -47.4% | 0.00% | – |
| Q2 2021 | $93,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $17,640,000 | 4.25% |
| BVF INC/IL | 1,201,717 | $8,244,000 | 0.92% |
| Orbimed Advisors | 3,670,955 | $25,183,000 | 0.39% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $945,000 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 475,450 | $3,262,000 | 0.12% |
| Hikari Power Ltd | 122,972 | $844,000 | 0.09% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 15,000 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 35,750 | $245,000 | 0.00% |
| DRW Securities, LLC | 10,000 | $69,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 134,542 | $923,000 | 0.00% |